ATE194839T1 - Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents

Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE194839T1
ATE194839T1 AT96400778T AT96400778T ATE194839T1 AT E194839 T1 ATE194839 T1 AT E194839T1 AT 96400778 T AT96400778 T AT 96400778T AT 96400778 T AT96400778 T AT 96400778T AT E194839 T1 ATE194839 T1 AT E194839T1
Authority
AT
Austria
Prior art keywords
alkyl
aryl
substd
arylalkyl
cycloalkyl
Prior art date
Application number
AT96400778T
Other languages
English (en)
Inventor
Marie-Claude Viaud
Gerald Guillaumet
Daniel Mazeas
Herve Vandepoel
Pierre Renard
Bruno Pfeiffer
Philippe Delagrange
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE194839T1 publication Critical patent/ATE194839T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
AT96400778T 1995-04-14 1996-04-11 Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen ATE194839T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9504504A FR2732969B1 (fr) 1995-04-14 1995-04-14 Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE194839T1 true ATE194839T1 (de) 2000-08-15

Family

ID=9478127

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96400778T ATE194839T1 (de) 1995-04-14 1996-04-11 Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Country Status (16)

Country Link
US (1) US5714495A (de)
EP (1) EP0737685B1 (de)
JP (1) JP3723274B2 (de)
CN (1) CN1058967C (de)
AT (1) ATE194839T1 (de)
AU (1) AU700071B2 (de)
CA (1) CA2174033C (de)
DE (1) DE69609371T2 (de)
DK (1) DK0737685T5 (de)
ES (1) ES2150642T3 (de)
FR (1) FR2732969B1 (de)
GR (1) GR3034620T3 (de)
NO (1) NO305988B1 (de)
NZ (1) NZ286360A (de)
PT (1) PT737685E (de)
ZA (1) ZA962934B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1178045T3 (da) * 1997-04-09 2003-06-23 Pfizer Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler
US5977131A (en) * 1997-04-09 1999-11-02 Pfizer Inc. Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR100378937B1 (ko) 1997-10-20 2003-05-09 에프. 호프만-라 로슈 아게 바이사이클릭 키나아제 억제제
CA2326143A1 (en) * 1998-04-02 1999-10-14 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US6025366A (en) * 1998-04-02 2000-02-15 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
AU3210799A (en) * 1998-04-02 1999-10-25 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US6228867B1 (en) 1998-04-02 2001-05-08 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
EP1067929A1 (de) * 1998-04-02 2001-01-17 Merck & Co., Inc. Gonadotropin-releasing-hormon antagonisten
US6110931A (en) * 1998-04-02 2000-08-29 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
WO1999051234A1 (en) * 1998-04-02 1999-10-14 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
PL350864A1 (en) * 1999-02-26 2003-02-10 Lilly Co Eli 5-ht1f
US6696439B1 (en) 1999-02-26 2004-02-24 Eli Lilly And Company 5-HT1F agonists
FR2799757B1 (fr) * 1999-10-15 2001-12-14 Adir Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SK288019B6 (sk) 1999-12-24 2012-11-05 Aventis Pharma Limited Azaindoles derivatives, their use and pharmaceutical composition containing thereof
GB0108770D0 (en) 2001-04-06 2001-05-30 Eisai London Res Lab Ltd Inhibitors
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
US6921762B2 (en) 2001-11-16 2005-07-26 Amgen Inc. Substituted indolizine-like compounds and methods of use
RU2362774C1 (ru) * 2002-02-01 2009-07-27 Астразенека Аб Хиназолиновые соединения
KR20050013534A (ko) 2002-03-28 2005-02-04 에자이 가부시키가이샤 ｃ─Ｊｕｎ Ｎ─말단 키나아제 억제용 아자인돌
CA2480317A1 (en) 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
EP1558252B1 (de) 2002-08-02 2007-10-10 Merck & Co., Inc. Substituierte furo[2,3-b]pyridin derivate
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
EP1599475A2 (de) * 2003-03-06 2005-11-30 Eisai Co., Ltd. Jnk-hemmer
EP1628975A2 (de) 2003-05-16 2006-03-01 Eisai Co., Ltd. Jnk inhibitoren
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
CN101010321B (zh) * 2004-09-03 2011-10-26 株式会社柳韩洋行 吡咯并[3,2-b]吡啶衍生物及其制备方法
JP4898683B2 (ja) * 2004-09-03 2012-03-21 ユーハン・コーポレイション ピロロ［２，３−ｃ］ピリジン誘導体及びその製造方法
US20060183758A1 (en) * 2005-02-17 2006-08-17 Cb Research And Development, Inc. Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
GB0516156D0 (en) 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
KR20080052630A (ko) * 2005-09-01 2008-06-11 어레이 바이오파마 인크. Ｒａｆ 억제제 화합물 및 그의 사용 방법
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
CN101605795A (zh) * 2006-12-08 2009-12-16 武田药品工业株式会社 三环化合物及其药物用途
WO2011109932A1 (en) * 2010-03-09 2011-09-15 F.Hoffmann-La Roche Ag Novel process for the manufacture of 5-halogenated-7-azaindoles
EP2940022B1 (de) * 2014-04-30 2020-09-02 Masarykova Univerzita Furopyridinen als Inhibitoren von Proteinkinasen
CN106045995B (zh) * 2016-06-13 2017-07-11 菏泽学院 一种5‑溴‑1H‑吡咯并[2,3‑b]吡啶的合成方法
US11168093B2 (en) 2018-12-21 2021-11-09 Celgene Corporation Thienopyridine inhibitors of RIPK2

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5552428A (en) * 1992-06-24 1996-09-03 Instituto Farmacologico Lombardo-Iflo, S.A.S. Compounds effective in the treatment of circadian rhythms and related disorders, the novel pharmaceutical preparations and novel method of application
WO1995033748A1 (en) * 1994-06-09 1995-12-14 Smithkline Beecham Corporation Endothelin receptor antagonists
WO1996004266A2 (de) * 1994-08-03 1996-02-15 Asta Medica Aktiengesellschaft Indol-, indazol-, pyridopyrrol- und pyridopyrazol-derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender wirkung
US5541228A (en) * 1994-10-14 1996-07-30 Bristol-Myers Squibb Co. Melatonergic agents

Also Published As

Publication number Publication date
EP0737685A1 (de) 1996-10-16
DK0737685T3 (da) 2000-10-09
JP3723274B2 (ja) 2005-12-07
PT737685E (pt) 2000-10-31
GR3034620T3 (en) 2001-01-31
FR2732969B1 (fr) 1997-05-16
EP0737685B1 (de) 2000-07-19
CA2174033C (fr) 2001-07-24
FR2732969A1 (fr) 1996-10-18
ES2150642T3 (es) 2000-12-01
DE69609371D1 (de) 2000-08-24
JPH08291172A (ja) 1996-11-05
NO305988B1 (no) 1999-08-30
AU700071B2 (en) 1998-12-17
CN1139111A (zh) 1997-01-01
NO961457L (no) 1996-10-15
CA2174033A1 (fr) 1996-10-15
US5714495A (en) 1998-02-03
ZA962934B (en) 1996-10-17
NO961457D0 (no) 1996-04-12
AU5062996A (en) 1996-10-24
NZ286360A (en) 1997-09-22
DE69609371T2 (de) 2001-02-22
DK0737685T5 (da) 2001-01-02
CN1058967C (zh) 2000-11-29

Similar Documents

Publication Publication Date Title
ATE194839T1 (de) Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DK131893D0 (da) 2-(substitueret methyl)-4-(substitueret ethoxy)-5-(lavere alkyl)-pyridinforbindelser, farmaceutisk praeparat, som indeholder saadanne samt anvendelse af en saadan forbindelse til fremstilling af et farmaceutisk praeparat
HUP0401293A2 (hu) Új dihidropteridinonok, eljárás előállításukra és alkalmazásuk gyógyszerként
NO933452L (no) Et terapeutisk middel for Parkinson's sykdom
DE58901510D1 (de) 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ES2056860T3 (es) Derivados de n-((2-oxopirrolidin-1-il)-acetil)piperazina y medicamento contra la demencia senil.
HUP0103020A2 (hu) Heterociklusos származékok mint FKBP inhibitorok, eljárás az előállításukra, köztitermékeik és ezeket tartalmazó gyógyszerkészítmények
ATE213496T1 (de) Heterozyclische verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE182325T1 (de) Tricyclische amidverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE212634T1 (de) Metalloproteaseinhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE101610T1 (de) Indol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE69611594D1 (de) Tetrazyclisch 1,4-Oxazinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE3675277D1 (de) Catechinamide, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zubereitung.
HUP0400304A2 (hu) Dihidroimidazo[5,1-a]-béta-karbolin-származékok, előállításuk és gyógyszerként való alkalmazásuk
MY101878A (en) 1,3,4-thiadiazole
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee